LILLY SELLING HALF-PRICE VERSION OF INSULIN

A half-price version of Eli Lilly’s popular Humalog insulin is available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices.

Lilly said it has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro. The Indianapolis drugmaker said insulin lispro will cost $137.35 per vial, or $265.20 for a package of five KwikPens, an easier-to-inject option.

Those figures are half the list price Lilly charges for Humalog. The fast-acting insulin, which diabetics inject shortly before each meal, is used by about 700,000 Americans.